Brimonidine Eye Drops within the Reach of Children: A Possible Foe

Daniela Trotta,Mirco Zucchelli,Carmela Salladini,Patrizia Ballerini,Claudia Rossi,Maurizio Aricò

DOI: https://doi.org/10.3390/children11030317

2024-03-07

Children

Abstract:Brimonidine, a selective alpha-2 adrenergic agonist used for the treatment of open-angle glaucoma, has been shown to cause neurological side effects such as unresponsiveness, lethargy, hypoventilation, and stupor, mimicking opioid toxicity. We report one case of transient encephalopathy in a toddler, in whom accidental brimonidine toxicity was suspected and then confirmed by a toxicology study. The healthy 8-month-old girl was taken to the pediatric ER since she was drowsy and hypotonic with miosis. The computed tomography scan of her brain and toxicological workup of her blood and urine were negative. Starting from the fourth hour, the child progressively improved, and by the sixth hour, she recovered to a normal state of consciousness. A survey of available drugs within the child’s reach showed the presence of brimonidine. Thus, ultra-performance liquid chromatography–tandem mass spectrometry (UPLC-MS/MS) was applied to quantify the brimonidine in urine and plasma samples, showing levels of 8.40 ng/mL and 0.79 ng/mL, respectively. To our knowledge, this is the first report to determine brimonidine levels in urine and plasma using UPLC-MS/MS. Insufficient knowledge on the part of family members about the potential hazards of an apparently innocuous, topical medication such as eye drops may put children at a greater risk of poisoning. Necessary warnings should be given to parents with greater care when prescribing this medication.

pediatrics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is related to the possible neurotoxic reactions in children after accidentally taking brinzolamide eye drops. Specifically, the researchers reported a case of an 8 - month - old baby girl who had transient encephalopathy due to accidental ingestion of brinzolamide, and this diagnosis was confirmed through toxicological studies. The paper explored the potential risks of brinzolamide in infants and young children, especially when this drug is accidentally ingested, it may lead to serious neurological side effects, such as unresponsiveness, lethargy, respiratory depression and stupor, etc., and these symptoms may be similar to the manifestations of opioid poisoning.

The paper also emphasized that the lack of awareness among family members of the potential hazards of such seemingly harmless topical medications (such as eye drops) may increase the risk of poisoning in children. Therefore, the paper calls on doctors to be more cautious in providing necessary warnings to parents when prescribing such drugs, in order to prevent the occurrence of similar events.